Rare diseases
Investigational molecules
Locations
Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
PortugalStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
PortugalStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
PortugalStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
PortugalStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
PortugalStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
PortugalStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
PortugalStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
PortugalStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
PortugalStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
PortugalStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
PortugalStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
